Multi-Center Randomized Controlled Trial of Relay- NYC's Nonfatal Overdose Response Program
Public ClinicalTrials.gov record NCT04317053. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The New York City (NYC) Department of Health and Mental Hygiene (DOHMH) has implemented Relay, a novel program that engages and intervenes with individuals in the ED following an opioid OD and for the next 90 days, with the goal of preventing subsequent OD events. The proposed randomized controlled trial will evaluate the impact of Relay on preventing subsequent opioid-related adverse events. A total of 350 eligible individuals with nonfatal opioid OD presenting to one of four participating EDs will be enrolled and randomized to one of two arms: 1) site-directed care (SDC) or 2) Relay-peer-delivered OD education and treatment linkage, including 90 days of peer navigation. Outcomes will be measured for 12 months through interviews and administrative health data.
Study identification
- NCT ID
- NCT04317053
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 253 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 7, 2020
- Primary completion
- Jun 30, 2023
- Completion
- Jun 30, 2023
- Last update posted
- Nov 24, 2024
2020 – 2023
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| NYU Langone Health | New York | New York | 10016 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Opioid Overdose trials
Other public records listing Opioid Overdose. Sorted by last update posted; newest first. Not a recommendation.
- NCT06271668: Clinical Decision Support to Improve System Naloxone Co-prescribing Active, not recruiting
- NCT06466005: UnityPhilly Response App for Overdose Reversal Recruiting
- NCT06429436: Vending Machine Naloxone Distribution for Your Community (VENDY) Recruiting
- NCT07485335: A Bundled Intervention to End Opioid Overdoses Not yet recruiting
- NCT06806163: Machine-Learning Prediction and Reducing Overdoses With EHR Nudges Recruiting
- NCT06593093: A Bundled Intervention Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04317053, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 24, 2024 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04317053 live on ClinicalTrials.gov.